Juli Miller | Head-Investor Relations |
Adrian Rawcliffe | Chief Executive Officer |
Dennis Williams | Senior Vice President, Late Stage Development |
Gavin Wood | Chief Financial Officer |
John Lunger | Chief Patient Supply Officer |
Elliot Norry | Chief Medical Officer |
Tony Butler | Roth |
Anthony Rodriguez | Cowen & Company |
Jonathan Chang | SVP Leerink |
Mara Goldstein | Mizuho Securities |
Danya Hail | Jones Research |
Good morning, everyone. Welcome to the Adaptimmune’s Q2 Financial and Business Update Conference Call. I would now like to turn the meeting over to Juli Miller. Please go ahead, Ms. Miller.